Christopher Lietz

Christopher Lietz is a highly experienced scientist currently serving as Senior Scientist II at Altos Labs since July 2024, where responsibilities include leading a team focused on pan-modality bioanalysis for various therapeutic modalities. From July 2018 to July 2024, Christopher held the position of Principal Scientist at Bristol Myers Squibb, leading a bioanalysis team and managing small molecule DMPK projects. Prior experiences include a role as Assistant Director of ADQC at Ionis Pharmaceuticals, focusing on late-stage analytical method development for antisense oligonucleotide drugs, and a postdoctoral fellowship at the University of California, San Diego, where research concentrated on biological mass spectrometry. Academic credentials include a PhD in Analytical Chemistry from the University of Wisconsin-Madison and a Bachelor of Science in Chemistry from Wayne State University.